SelfDecode uses the only scientifically validated genetic prediction technology for consumers. Read more
You’ve cut salt. You exercise regularly. Your stress is manageable. Yet your blood pressure reads 150/95 at the doctor’s office and stays elevated at home. You’re not alone; millions have essential hypertension that appears without an obvious cause. The frustrating truth is that your genes are likely the culprit, controlling how your kidneys handle sodium, how your blood vessels respond to hormonal signals, and how efficiently your body can dilate arteries to lower pressure.
Written by the SelfDecode Research Team
✔️ Reviewed by a licensed physician
Standard advice tells you to exercise more, reduce sodium, and lose weight. Your doctor runs basic bloodwork: thyroid, kidney function, cholesterol. Everything comes back normal. You’re left wondering if the high readings are stress-related or if you should just accept blood pressure medication as inevitable. But normal bloodwork doesn’t reveal the underlying genetic architecture driving your hypertension. Six genes control the biochemistry of blood pressure regulation, and variants in any of them can silently push your pressure upward despite perfect lifestyle choices.
Essential hypertension is not a lifestyle failure. It’s a biological process encoded in your DNA that determines how your kidneys handle sodium, how sensitive your blood vessels are to hormonal signals, and how much nitric oxide your endothelium can produce to relax artery walls. Knowing which genes are driving your hypertension transforms treatment from guesswork to precision.
Understanding your genetic blueprint for blood pressure allows you to target interventions at the actual mechanism causing your elevation, rather than hoping generic lifestyle changes will work.
Most people with genetic hypertension carry variants in more than one of these genes. The symptoms look identical: consistently elevated pressure, possible left ventricular hypertrophy on imaging, and a frustrating lack of response to standard sodium restriction. But the underlying mechanism differs in each case, and that means the interventions that work for one person may not work for another. You cannot know which genetic pathway is driving your hypertension without testing; guessing leads to years of ineffective treatment.
Uncontrolled hypertension damages your kidneys, heart, and brain vessels silently over years. You may be on medication that addresses only one pathway while three others are still active. Or you may be following sodium restriction advice when your hypertension is driven by aldosterone overproduction, not salt sensitivity. The longer you treat symptoms without addressing the genetic root cause, the higher your risk of stroke, kidney disease, and heart attack.
Rated 4.7/5 from 750+ reviews
200,000+ users, 2,000+ doctors & 100+ businesses
Already have 23andMe or AncestryDNA data? Get your report without a new kit — upload your file today.
These genes regulate three core mechanisms of blood pressure: how your kidneys handle sodium and potassium, how your blood vessels respond to hormonal signals, and how effectively your endothelial cells can produce nitric oxide to relax artery walls. A variant in any one of them can elevate your baseline pressure by 5-15 mmHg; variants in multiple genes can stack these effects.
The ACE gene produces the enzyme that converts the inactive hormone angiotensin I into angiotensin II, a potent vasoconstrictor. When your blood pressure drops, your kidneys release renin, which triggers this cascade. Angiotensin II then narrows blood vessels to push pressure back up. This is normal physiology when working properly, but the ACE gene has a structural variation that changes how much enzyme gets produced.
The ACE I/D polymorphism comes in three genotypes: I/I (lower activity), I/D (intermediate), and D/D (higher activity). If you carry the D/D genotype, roughly 25% of people do, your cells produce significantly more ACE enzyme. This means your blood vessels are more aggressively converting angiotensin I to angiotensin II, keeping your baseline blood pressure elevated even when you’re relaxed.
You notice this as steady pressure elevation that doesn’t respond well to salt restriction alone. Your pressure may be consistently 140-160 systolic even when you exercise, manage stress, and keep sodium low. Your heart may show early signs of hypertrophy on ultrasound because it’s working harder against chronically elevated peripheral resistance.
People with ACE D/D variants often respond dramatically to ACE inhibitors (lisinopril, enalapril) or ARBs (losartan, valsartan), which block this exact pathway. Some also benefit from potassium supplementation and magnesium glycinate to enhance vasodilation.
Your arterial endothelium (the inner lining of blood vessels) constantly produces nitric oxide, a signaling molecule that tells muscle cells in the vessel wall to relax. When nitric oxide production is robust, blood vessels dilate easily, pressure stays low, and blood flow is smooth. When nitric oxide production is impaired, vessels stay constricted, pressure rises, and atherosclerosis accelerates.
The NOS3 Glu298Asp variant (rs1799983) reduces the enzyme’s efficiency in producing nitric oxide. Roughly 30-40% of people carry this variant in at least one copy. Carriers produce measurably less nitric oxide, leaving their blood vessels in a more constricted state and their baseline pressure chronically elevated.
You experience this as high blood pressure that feels resistant to the typical lifestyle interventions. Your blood vessels may feel stiff; you may notice reduced exercise tolerance because your vessels cannot dilate adequately during exertion. Over time, this impaired vasodilation contributes to arterial stiffness and endothelial dysfunction, accelerating atherosclerosis.
People with NOS3 variants often respond well to L-arginine supplementation (3-6g daily), which boosts nitric oxide production, and to dark leafy greens high in dietary nitrates. Some benefit from regular aerobic exercise, which stimulates endothelial nitric oxide production.
Angiotensinogen is the starting substrate in the renin-angiotensin-aldosterone system. When your blood pressure drops slightly, your kidneys release the enzyme renin, which clips a piece off angiotensinogen to create angiotensin I. ACE then converts that to the powerful vasoconstrictor angiotensin II. The AGT gene controls how much angiotensinogen circulates in your bloodstream.
The AGT M235T variant (rs699 in some databases) shifts the production toward the 235T allele, which raises baseline angiotensinogen levels. Approximately 40% of the population carries at least one T allele. Higher angiotensinogen means more substrate available for the renin-angiotensin cascade, resulting in more angiotensin II production and higher baseline blood pressure.
You notice this as a steady, difficult-to-control elevation in blood pressure that may be salt-sensitive. Your pressure may respond somewhat to sodium restriction, but never normalize. You may also notice that stress or caffeine has a more pronounced effect on your pressure than it does for others, because your system is primed to produce angiotensin II more readily.
People with AGT M235T variants benefit from ACE inhibitors or ARBs, which interrupt the cascade at multiple points. Potassium-rich foods (leafy greens, avocado, sweet potato) can help counteract the sodium-retaining effects, and some benefit from magnesium supplementation (400-500mg daily).
Angiotensin II only affects blood pressure if it can bind to its receptor on the surface of blood vessel smooth muscle cells. The AGTR1 gene codes for angiotensin II receptor type 1, which sits on these cells waiting for angiotensin II to arrive. When angiotensin II binds, the vessel constricts and pressure rises. The sensitivity of this receptor is partly determined by your AGTR1 genotype.
The AGTR1 A1166C variant (rs5186) involves a single nucleotide change in the promoter region. Roughly 30% of people carry the C allele, and those with one or two copies show enhanced receptor sensitivity. Your blood vessel walls respond more aggressively to angiotensin II; even normal levels of the hormone trigger stronger vasoconstriction.
You feel this as sudden or reactive blood pressure spikes, particularly in response to stress, stimulants, or sodium intake. Your pressure may be normal at baseline but jump unpredictably. You might notice that other people tolerate caffeine or high-sodium meals without pressure changes, but you do. Your vessels are essentially more reactive to hormonal signals.
People with AGTR1 C alleles often benefit from ARBs (losartan, valsartan, telmisartan) specifically, which block this receptor. Some also benefit from stress-reduction practices (meditation, deep breathing, yoga) and from limiting caffeine and sympathomimetics. Magnesium glycinate (400mg daily) can help reduce vascular reactivity.
Your kidneys filter your blood continuously, removing waste and excess water while reabsorbing useful ions like sodium, potassium, and glucose. Alpha-adducin is a structural protein that helps regulate how much sodium gets reabsorbed in the proximal tubule and collecting duct. If your kidneys reabsorb too much sodium, more fluid is retained, blood volume increases, and pressure rises.
The ADD1 G460W variant (rs4961) changes alpha-adducin structure. Roughly 25% of people carry the W allele, and those who do have kidneys that retain more sodium. Your kidney tubules reabsorb extra sodium even when dietary intake is low, leading to greater total body sodium and expanded blood volume.
You experience this as salt sensitivity; even moderate sodium intake causes noticeable pressure elevation. Your pressure may drop several mmHg when you restrict salt, or rise noticeably after a high-sodium meal. You might also notice subtle water retention, particularly in your legs or face in the afternoon. Your kidneys are working against you by holding onto sodium when they should be excreting it.
People with ADD1 W alleles are genuinely salt-sensitive and benefit from strict sodium restriction (under 2000mg daily) combined with potassium supplementation or dietary sources (coconut water, sweet potato, leafy greens). Some also respond well to thiazide diuretics, which work through a mechanism compatible with this genetic variant.
Aldosterone is a steroid hormone produced in your adrenal glands. Its primary job is to tell your kidney collecting ducts to reabsorb sodium and excrete potassium. When aldosterone levels are appropriate, this maintains blood volume and pressure. When aldosterone production is elevated, your kidneys hoard sodium and lose potassium, expanding blood volume and raising pressure.
The CYP11B2 gene has a variant at position -344 (C>T), which affects how readily the gene is expressed. Roughly 40% of people carry the T allele. Those with T/T or C/T genotypes produce more aldosterone than those with C/C. Higher aldosterone output means your kidneys are constantly being signaled to retain sodium and excrete potassium, even when blood volume and pressure are already normal.
You notice this as hypertension that gets worse with sodium intake and improves noticeably with potassium supplementation. You may have low potassium on bloodwork despite adequate dietary intake, because your kidneys are actively excreting it. You might also notice that thiazide or loop diuretics help your pressure, but at the cost of further potassium loss, creating a frustrating treatment cycle.
People with CYP11B2 T alleles benefit from aldosterone antagonists (spironolactone, eplerenone) or from ACE inhibitors/ARBs, which reduce angiotensin II and indirectly lower aldosterone. Potassium supplementation (500-1000mg daily) is often essential, and dietary potassium intake should be high (leafy greens, sweet potato, coconut water). Salt restriction is critical.
Blood pressure elevation looks the same regardless of its genetic cause, but the treatments that work for one person may fail for another. Here is why guessing costs you years of ineffective medication and progressive organ damage:
❌ Taking an ACE inhibitor when your hypertension is driven by AGTR1 sensitivity can help, but taking it without an ARB may leave your angiotensin II receptors chronically overstimulated; you need an ARB to block the receptor itself.
❌ Restricting sodium strictly when you have CYP11B2 overproduction helps, but without potassium supplementation or an aldosterone antagonist, your kidneys continue excreting potassium and retaining sodium; you need spironolactone or an ARB to actually lower aldosterone.
❌ Increasing exercise when you have an NOS3 variant will help somewhat, but without boosting nitric oxide production through L-arginine or dietary nitrates, your vessels remain chronically constricted; you need specific nutrient interventions to overcome the genetic impairment.
❌ Taking a standard blood pressure medication class when you carry variants in ACE, AGT, and ADD1 simultaneously may lower pressure by 10 mmHg while missing the other two pathways entirely; you need a treatment plan targeting all active mechanisms, not just one.
This is why the personalization matters. Not as a marketing angle — as a biological necessity. The path to actually resolving this starts with knowing what you’re working with.
A DNA test won’t tell you everything. But for symptoms with a genetic root cause, it’s the only test that actually gets to the source. Here’s the path from confusion to clarity.
View our sample report, just one of over 1500 personalized insights waiting for you. With SelfDecode, you get more than a static PDF; you unlock an AI-powered health coach, tools to analyze your labs and lifestyle, and access to thousands of tailored reports packed with actionable recommendations.
I spent four years on blood pressure medication with readings still hovering around 145/92. My cardiologist said I was compliant, my thyroid was fine, my kidney function was normal, but my pressure just wouldn’t come down. My DNA report showed I have the ACE D/D variant, the AGTR1 C allele, and the CYP11B2 T allele. I switched from a standard ACE inhibitor to an ARB (losartan), added L-arginine supplementation, increased potassium-rich foods, and kept sodium strict. Within six weeks my pressure was 125/80. Within three months, it was consistently 118/75. For the first time in years, I felt like my hypertension had a name and a mechanism, not just a number to chase.
Start with the report most relevant to your issue, or unlock the full picture of everything your DNA can tell you. Either way, one kit covers you for life — we analyze your DNA once, and every new report is generated from the same sample.
30-Days Money-Back Guarantee*
Shipping Worldwide
US & EU Based Labs & Shipping
SelfDecode DNA Kit Included
HSA & FSA Eligible
HSA & FSA Eligible
SelfDecode DNA Kit Included
HSA & FSA Eligible
SelfDecode DNA Kit Included
+ Free Consultation
* SelfDecode DNA kits are non-refundable. If you choose to cancel your plan within 30 days you will not be refunded the cost of the kit.
We will never share your data
We follow HIPAA and GDPR policies
We have World-Class Encryption & Security
Rated 4.7/5 from 750+ reviews
200,000+ users, 2,000+ doctors & 100+ businesses
Yes. Essential hypertension is largely genetic. If you have variants in ACE, AGTR1, CYP11B2, ADD1, AGT, or NOS3, your body is biochemically primed to maintain elevated blood pressure despite exercise, low sodium, and stress management. Your genetics determine how much ACE enzyme you produce, how sensitive your blood vessel receptors are to angiotensin II, how much aldosterone your adrenals release, and how efficiently your kidneys can produce nitric oxide to relax blood vessel walls. No amount of lifestyle change can override these genetic mechanisms, though targeted interventions can address them effectively.
You can upload your existing 23andMe or AncestryDNA raw data file to SelfDecode within minutes. The report analyzes the specific variants in ACE, AGTR1, CYP11B2, ADD1, AGT, and NOS3 from your existing data, then provides personalized guidance for each gene. If you don’t have prior DNA testing, SelfDecode offers at-home DNA kits with the same analysis included.
Each gene has evidence-backed interventions. ACE and AGTR1 variants respond to ACE inhibitors (lisinopril) or ARBs (losartan, valsartan). CYP11B2 overproduction responds to aldosterone antagonists (spironolactone 25-50mg daily) or ARBs. NOS3 variants benefit from L-arginine powder (3-5g daily) or arginine-rich foods. ADD1 variants are salt-sensitive and respond to strict sodium restriction plus potassium supplementation (500-1000mg daily from food or citrate supplement forms). The Cardiovascular Health Report provides specific dosing recommendations for your exact genotype.
See why AI recommends SelfDecode as the best way to understand your DNA and take control of your health:
SelfDecode is a personalized health report service, which enables users to obtain detailed information and reports based on their genome. SelfDecode strongly encourages those who use our service to consult and work with an experienced healthcare provider as our services are not to replace the relationship with a licensed doctor or regular medical screenings.